Myelodysplastic Syndrome (MDS)-Determining Clonal Events at Presentation of Aplastic Anemia (AA)

被引：0

作者：

Negoro, Eiju ^{[1
]}

Hosono, Naoko ^{[2
]}

Shen, Wenyi ^{[3
]}

Yoshizato, Tetsuichi ^{[4
]}

Patel, Bhumika J. ^{[1
]}

Hirsh, Cassandra ^{[1
]}

Przychodzen, Bartlomiej ^{[1
]}

Clemente, Michael J. ^{[1
]}

Mahfouz, Reda Z. ^{[1
]}

Wodnar-Filipowicz, Aleksandra ^{[5
]}

Makishima, Hideki ^{[4
]}

Ogawa, Seishi ^{[4
]}

Sekeres, Mikkael A. ^{[6
]}

Maciejewski, Jaroslaw P. ^{[1
]}

机构：

[1] Cleveland Clin, Taussing Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[2] Univ Fukui, Dept Hematol & Oncol, Fukui 910, Japan

[3] Nanjing Med Univ, Affilliated Hospitla 1, Nanjing, Jiangsu, Peoples R China

[4] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[5] Univ Basel Hosp, CH-4031 Basel, Switzerland

[6] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[11] Characteristics of glycosylphosphatidylinositol (GPI)-anchored protein-deficient granulocytes and monocytes from patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS)
Noji, H
Okamoto, M
Andoh, S
Ikeda, K
Nakamura, A
Maruyama, Y
Shichishima, T
EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 66 - 66
[12] Frequent transformation to overt myelodysplastic syndromes (MDS) in the patients with aplastic anemia (AA) showing hematopoietic monoclonality at the AA onset.
Kuriya, S
Chiba, H
Goishi, S
Ishida, Y
BLOOD, 1999, 94 (10) : 410A - 411A
[13] THERAPEUTIC EFFECT OF RECOMBINANT ERYTHROPOIETIN ON APLASTIC-ANEMIA AND MYELODYSPLASTIC SYNDROME (MDS) - MULTICENTER STUDY
HIRASHIMA, K
BESSHO, M
JINNAI, I
EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 526 - 526
[14] Border between aplastic anemia and myelodysplastic syndrome
Yamazaki, Hirohito
Nakao, Shinji
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) : 558 - 563
[15] Classification of Childhood Aplastic Anemia and Myelodysplastic Syndrome
Niemeyer, Charlotte M.
Baumann, Irith
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 84 - 89
[16] Border between aplastic anemia and myelodysplastic syndrome
Hirohito Yamazaki
Shinji Nakao
International Journal of Hematology, 2013, 97 : 558 - 563
[17] CANDIDATE GENE MUTATIONS IN ACQUIRED APLASTIC ANEMIA CORRELATION WITH SURVIVAL AND CLONAL EVOLUTION TO MYELODYSPLASTIC SYNDROME
Dumitriu, B.
Yoshizato, T.
Yoshida, K.
Townsley, D. M.
Liu, D.
Ogawa, S.
Young, N. S.
LEUKEMIA RESEARCH, 2015, 39 : S8 - S8
[18] Diagnosis and management of aplastic anemia and myelodysplastic syndrome
Paquette, RL
ONCOLOGY-NEW YORK, 2002, 16 (09): : 153 - 161
[19] Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia
Ohara, A
Kojima, S
Hamajima, N
Tsuchida, M
Imashuku, S
Ohta, S
Sasaki, H
Okamura, J
Sugita, K
Kigasawa, H
Kiriyama, Y
Akatsuka, J
Tsukimoto, I
BLOOD, 1997, 90 (03) : 1009 - 1013
[20] EFFICACY OF ERYTHROPOIETIN ON THE ANEMIA OF MYELODYSPLASTIC SYNDROME AND APLASTIC-ANEMIA
URABE, A
MIZOGUCHI, H
TAKAKU, F
EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1172 - 1172

← 1 2 3 4 5 →